Treatment approaches to nasopharyngeal carcinoma: a review.
about
Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaOptimal management of a patient with recurrent nasopharyngeal carcinoma.Identification of heat shock protein 27 as a radioresistance-related protein in nasopharyngeal carcinoma cells.Identification and analysis of the promoter region of the STGC3 gene.Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinomaTherapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation.Combined chemo-radiotherapy in locally advanced nasopharyngeal carcinomas.Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotypeLong-Term Outcomes of Nasopharyngeal Carcinoma in 148 Children and Adolescents.A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation.FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition.CFTR is a potential marker for nasopharyngeal carcinoma prognosis and metastasisLocally advanced nasopharyngeal carcinoma: Current and emerging treatment strategies.The adolescent and young adult with cancer: state of the art--epithelial cancer.Step-by-step full mouth rehabilitation of a nasopharyngeal carcinoma patient with tooth and implant-supported prostheses: A clinical report.Down-regulation of BMI-1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells.The 656C and 725C are two important sites in gene STGC3 for its negative regulation on cell growthPreclinical evaluation of PI3K inhibitor BYL719 as a single agent and its synergism in combination with cisplatin or MEK inhibitor in nasopharyngeal carcinoma (NPC).Long-term results of concurrent chemoradiotherapy for T3/T4 locally advanced nasopharyngeal carcinoma.Zoledronic acid inhibits proliferation and impairs migration and invasion through downregulating VEGF and MMPs expression in human nasopharyngeal carcinoma cells.Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma.Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.Impact of diabetes mellitus on the risk and survival of nasopharyngeal carcinoma: a meta-analysis.Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma.T4-locally advanced nasopharyngeal carcinoma: prognostic influence of cranial nerve involvement in different radiotherapy techniques.Camptothecin inhibits the progression of NPC by regulating TGF-β-induced activation of the PI3K/AKT signaling pathway.
P2860
Q27016002-17B0F12F-B897-4FF0-B2EF-B14061E8108AQ33898262-3F637C0B-F277-42B0-BF4E-89F092F37D4FQ34357264-978AE669-56AA-4D2E-83BC-28DC8B74A17EQ36220615-C3D5D5CE-D59E-41CB-91B7-D4E8A2DF25FFQ36418335-15DE80C5-7FDE-4BA5-859E-E21139A0E584Q36738925-F6F9654F-3842-4B1F-9AB1-0948AE3F2CA9Q36859963-FD2AB3C9-EF40-4BA0-AD14-E9A3D65C314CQ36983775-90BA7348-5CB9-4E2C-8121-853CFD18FEC2Q37206380-A2DCE43B-D147-4B4E-B81C-A8FDC25C4E03Q37327734-77670537-9576-4404-8A88-F518B92466A1Q37716550-FF20B7C5-029B-419A-BA17-7231C4C103F0Q37718318-64320675-7783-408F-B445-DFB93B63A04DQ37968598-BC59D0F9-5709-4605-961B-B175A9CF02CFQ38113517-61B67AF5-2A98-44CF-9429-CA9263162DD7Q39057014-49244EB3-8A2E-4705-8790-B6EA524C18BBQ39568963-03F47B46-EB7E-4980-88B6-F2F64F46C211Q40742844-BC471089-024E-4823-B6CE-56B17BB3E7C6Q40809231-2B1F4295-06A8-479B-BEFC-65E6B73B6765Q41923470-693486C3-2E5A-4642-A3AB-66387D28AFBFQ44240872-8C5A78BF-242A-46A3-A18B-FCFD16DA50E2Q46383461-50F0193C-53A8-41A2-B597-0DF9640538F7Q47639200-8ED459A2-3506-4E2E-BD36-1452B0E7EDCEQ50431396-F2428A02-64F4-47C8-984F-94B0138DE3A0Q52657234-22053908-448E-4D69-9EA6-B8A815A0FF66Q53700212-C0F3E7BC-91DE-42E2-8796-F32278AC7B80Q54377245-E0638D06-AE35-4CE9-A4A2-41B3CB6E7E66Q55348670-C9222706-64FA-45F1-B14F-929AB692EA7E
P2860
Treatment approaches to nasopharyngeal carcinoma: a review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment approaches to nasopharyngeal carcinoma: a review.
@en
Treatment approaches to nasopharyngeal carcinoma: a review.
@nl
type
label
Treatment approaches to nasopharyngeal carcinoma: a review.
@en
Treatment approaches to nasopharyngeal carcinoma: a review.
@nl
prefLabel
Treatment approaches to nasopharyngeal carcinoma: a review.
@en
Treatment approaches to nasopharyngeal carcinoma: a review.
@nl
P50
P1433
P1476
Treatment approaches to nasopharyngeal carcinoma: a review
@en
P2093
Francesco Caponigro
P304
P356
10.1097/CAD.0B013E328337160E
P577
2010-06-01T00:00:00Z